Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
91,192,604
-
Shares change
-
+2,575,089
-
Total reported value, excl. options
-
$2,876,445,823
-
Value change
-
+$72,474,589
-
Put/Call ratio
-
73.74%
-
Number of buys
-
73
-
Number of sells
-
-41
-
Price
-
$31.53
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q3 2021
156 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,192,604 shares
of 171,717,172 outstanding shares and own 53.11% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), FMR LLC (13,686,804 shares), BlackRock Inc. (5,352,612 shares), VANGUARD GROUP INC (4,884,037 shares), Bellevue Group AG (3,755,962 shares), Casdin Capital, LLC (3,668,574 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3,050,702 shares), STATE STREET CORP (2,681,676 shares), BVF INC/IL (2,049,113 shares), and PERCEPTIVE ADVISORS LLC (1,943,097 shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.